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In the last decade, much attention has been devoted to the effects of nutrient-related
signals on brain development and cognitive functions. A turning point was the discovery
that brain areas other than the hypothalamus expressed receptors for hormones related
to metabolism. In particular, insulin signaling has been demonstrated to impact on
molecular cascades underlying hippocampal plasticity, learning and memory. Here,
we summarize the molecular evidence linking alteration of hippocampal insulin sensitivity
with changes of both adult neurogenesis and synaptic plasticity. We also review the
epidemiological studies and experimental models emphasizing the critical role of brain
insulin resistance at the crossroad between metabolic and neurodegenerative disease.
Finally, we brief novel findings suggesting how biomarkers of brain insulin resistance,
involving the study of brain-derived extracellular vesicles and brain glucose metabolism,
may predict the onset and/or the progression of cognitive decline.
Keywords: brain insulin resistance, hippocampus, Alzheimer’s disease, synaptic plasticity, adult neurogenesis
INTRODUCTION
Since the discovery of insulin almost a century ago, much efforts have been conducted to study
the effects of this hormone on all organs. Insulin was originally shown to act on the brain by
stimulating the hypothalamic satiety center and inhibiting the feeding behavior (Debons et al.,
1970). For long time the impact of insulin on other brain areas remained unknown because the
central nervous system was considered a non-insulin dependent tissue. In the last decades, the
discovery of insulin receptor (IR) expression in brain areas involved in functions different from
the feeding control, such as learning and memory, has revolutionized this idea and paved the way
for the understanding of how the brain is a highly insulin-sensitive organ (Hill et al., 1986; Zhao
and Alkon, 2001). Brain plasticity, the capability of this organ to undergo structural and functional
changes in response to environmental stimuli, is finely modulated by diet and nutrient-dependent
hormones including insulin (Mainardi et al., 2015). Accordingly, alteration of insulin signaling
into the central nervous system may accelerate brain aging, affect brain plasticity and promote
neurodegeneration (Kullmann et al., 2016).
Here, we review the effects of insulin on hippocampus, a brain area playing a pivotal role in
learning and memory and primarily affected in Alzheimer’s disease (AD) (Bartsch and Wulff,
2015). First, we will describe the effects of insulin on both hippocampal synaptic plasticity and
hippocampal adult neurogenesis. In addition, we will illustrate the crosstalk between insulin and
neurotrophin signaling, the impact of insulin on cognitive function and the role of its signaling on
brain aging. Moreover, we will describe how alteration of brain insulin signaling develops (i.e.,
brain insulin resistance, hereinafter named BIR) and we will summarize the effects of BIR on
hippocampal plasticity, learning and memory along with the link between BIR and AD.
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Finally, we will discuss novel evidence suggesting that both
brain-derived extracellular vesicles and brain glucose metabolism
may represent novel biomarkers of BIR able to predict and follow
up cognitive decline.
INSULIN AND BRAIN PLASTICITY
Neurons are high energy-consuming cells. Most energy is spent
to generate action and postsynaptic potentials (Howarth et al.,
2012), and for the biosynthesis of neurotransmitters (Dienel,
2012). Glucose is the main energy source used by brain cells
and its transport across the plasma membrane is mediated
by a specific family of membrane proteins known as glucose
transporters (GLUTs) (Shepherd and Kahn, 1999). Though
numerous GLUT isoforms (1–14) have been identified and
characterized, only some of these transporters are expressed in
the brain and can be involved in neuronal homeostasis and brain
function (Duelli and Kuschinsky, 2001). Specifically, the insulin-
independent transporters GLUT1 and GLUT3 mediate glucose
uptake into glial and neuronal cells, respectively (Simpson et al.,
2007), suggesting that the impact of insulin on synaptic plasticity
should be independent of glucose uptake.
Moreover, GLUT2 and GLUT4 expression has been
characterized in specific brain areas: GLUT2 is predominantly
localized in the hypothalamus that regulates food intake (Eny
et al., 2008), whereas GLUT4 has been identified in cerebellum,
neocortex, and hippocampus, suggesting a role of GLUT-driven
glucose uptake in neuronal activity (Vannucci et al., 1998;
Sankar et al., 2002). GLUT4 is also expressed in astrocytes and
insulin stimulation promotes both glucose uptake and glycogen
accumulation in astrocyte cultures (Heni et al., 2011). However,
not much data are available in the literature on the role of insulin
on astrocytic functions. GLUT5 expression is less relevant and
mainly detected in human and rat brain microglia (Payne et al.,
1997). GLUT6 and GLUT13, which have very low affinity to
glucose, are also expressed in the brain, but their role in central
nervous system has yet to be clarified (Joost and Thorens, 2001).
Conversely, GLUT8 has been shown to drive hippocampal
neuron proliferation during embryogenesis (Membrez et al.,
2006). However, tissue/cell type specific expression of GLUTs
in the brain still remains matter of debate. Further, several
growth factors have been reported to modulate the insulin
pathway, GLUT plasma membrane translocation and glucose
uptake by transactivation of the IR downstream effectors
(Assefa et al., 2017).
In this section, we brief the insulin cascade effectors and the
effects of this hormone on both synaptic plasticity and adult
neurogenesis in the hippocampus along with their impact on
cognitive functions.
Insulin Signaling in the Brain
Insulin and the insulin-like growth factor 1 (IGF-1) exert
their biological effects through two tyrosine kinase receptors,
the IR and the IGF-1 receptors (IGF-1R), which are closely
related and highly distributed throughout the brain (Belfiore
et al., 2009). In the mouse, IR is predominantly expressed
in the olfactory bulb, hippocampus, neocortex, hypothalamus,
and cerebellum, whereas IGF-1R is highly expressed in the
hippocampus, neocortex, and thalamus, with lower expression
in the hypothalamus, cerebellum, olfactory bulb, midbrain,
and brainstem (Bruning et al., 2000; Fernandez and Torres-
Aleman, 2012). As reported in other tissues, IRs and IGF-
1Rs can heterodimerize in the brain and partially transactivate
their signaling (Bailyes et al., 1997). Moreover, IR and IGF-
1R share intracellular signaling machinery, and all major
components of brain signaling cascades are similar to those
present in peripheral tissues, including IR substrate 1 and
2 (IRS1 and IRS2, respectively), the major downstream
phosphoinositide-3-kinase–protein kinase B/Akt (PI3K/Akt)
pathway, the downstream effectors target of rapamycin (mTOR)
and glycogen synthase kinase 3 beta (GSK3β), and the
transcription factors cAMP response element-binding protein
(CREB) and forkhead box O (FOXO) family (Fernandez and
Torres-Aleman, 2012; Figure 1).
Many molecules involved in these signaling cascades have
been demonstrated to have key roles in brain functions.
Activation of PI3-kinase is required for glutamate receptor
insertion at plasma membranes during synaptic plasticity
(Man et al., 2003). GSK3β regulates neural progenitor cell
proliferation and neuroplasticity, and its activation induces
hyper-phosphorylation of tau protein that is considered a major
determinant of AD pathogenesis (Salcedo-Tello et al., 2011).
Insulin induces phosphorylation of GSK3β on inhibitory serine
9 residue, thus reducing its enzymatic activity. Moreover, mTOR
complex 1 (mTORC1) is fundamental for both protein synthesis
and autophagy, which are molecular processes involved in the
regulation of long-term synaptic plasticity and degradation of
misfolded proteins in neurons, respectively (Stoica et al., 2011;
Son et al., 2012). Insulin/IGF-1 signaling also stimulates the
growth factor receptor-bound protein 2- Son of Sevenless-
Rat sarcoma-mitogen activated protein kinase (Grb2-SOS-Ras-
MAPK) cascade, which plays a pivotal role in cytoskeletal
modifications underlying the dendritic spine reorganization and
memory formation (Adams and Sweatt, 2002).
The origin of insulin in the central nervous system is
controversial. Insulin crosses the blood-brain barrier (BBB) via
an IR-dependent transport operated by vascular endothelium
and its concentration increases after meals (Woods et al.,
2003). However, insulin can be also synthesized and secreted by
neurons and adult neural progenitor cells of the hippocampus
(Devaskar et al., 1994; Kuwabara et al., 2011), although no
evidence clearly demonstrated that insulin synthesis in the brain
is physiologically relevant.
However, as described in the next paragraphs, physiological
levels of insulin play a neurotrophic action on both differentiated
neurons and neural stem cells (NSCs).
Insulin, Synaptogenesis and
Hippocampal Synaptic Plasticity
Modifications of both activity and number of synapses
are the functional and structural substrates, respectively,
of brain plasticity underlying learning and memory
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FIGURE 1 | Insulin signaling. IR, Insulin receptor; IRS1 and IRS2, IR substrate 1 and 2; PI3K, phosphoinositide-3-kinase–protein kinase B; AKT, protein kinase B;
mTOR, target of rapamycin; GSK3β, glycogen synthase kinase 3 beta; GRB2, growth factor receptor-bound protein 2; SOS, Son of Sevenless; RAS, Rat sarcoma
GTPase protein; MAPK, mitogen activated protein kinase; FOXO, forkhead box O transcription factor; CREB, cAMP response element-binding protein.
(Nakahata and Yasuda, 2018). Changes of the synaptic strength,
either potentiation or depression, and generation of new
dendritic spines are causally related to the acquisition and
consolidation of behavioral modifications.
Insulin stimulation of hippocampal neurons induces both
presynaptic and postsynaptic effects. Insulin increases basal
neurotransmitter release from presynaptic terminals, as revealed
by enhanced frequency of miniature excitatory postsynaptic
currents (mEPSCs) (Lee et al., 2011). This effect is paralleled
by a Rac1-mediated cytoskeleton rearrangement leading
to increased density of dendritic spines (Lee et al., 2011).
Moreover, insulin promotes synaptic plasticity by modulating
long-term potentiation (LTP) or long-term depression (LTD)
at hippocampal synapses through a metaplastic mechanism.
Indeed, insulin administration reduces the stimulation frequency
threshold required for inducing both LTP and LTD (Van Der
Heide et al., 2005). Postsynaptic effects are mediated by PI3K
activation (Van Der Heide et al., 2005) and increased membrane
recruitment of N-methyl-D-aspartate receptors (NMDARs)
(Skeberdis et al., 2001). Insulin impacts on glutamate receptor
activity by multiple mechanisms. It increases NMDAR-mediated
currents by enhancing phosphorylation of both NR2A and NR2B
subunits (Christie et al., 1999; Liu et al., 1995). Insulin treatment
of hippocampal cultures also increases phosphorylation
and clathrin-dependent endocytosis of the GluA1 subunit
of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
receptors (AMPARs) (Adzovic and Domenici, 2014; Chen et al.,
2014). Downregulation of AMPAR activity in excitatory synapse
of hippocampal CA1 neurons is fundamental for insulin-induced
LTD, which is a key step for memory consolidation and flexibility
(Ge et al., 2010). IRs have also been demonstrated to modulate
type A γ-aminobutyric acid (GABA) receptor activity by
regulating both its membrane localization and expression in
inhibitory synapses (Wan et al., 1997).
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Furthermore, insulin may impinge on structural features of
synapses. For instance, in thalamocortical organotypic slices
this hormone stimulates maturation of silent synapses (Plitzko
et al., 2001). Moreover, IR substrate p53 (IRSp53) interacts
with the postsynaptic protein PSD-95 and enhances dendritic
spine formation (Choi et al., 2005). Interestingly, IRS2 knockout
mice show lower activation of NR2B subunits (Martin et al.,
2012) and decreased LTP at the CA3–CA1 synapses in parallel
with higher density of CA1 dendritic spines (Irvine et al.,
2011). It is important to underline that these studies did not
evaluate dendritic spine morphology, therefore our knowledge
of the effects of IRSs manipulation on structural and functional
plasticity still remains incomplete. Considering the physical
and functional interaction between IR and IGF-1R, it is not
surprising that IGF-1 stimulation can promote plasticity in
the hippocampus by increasing spine density of CA1 basal
dendrites in response to physical exercise (Glasper et al.,
2010). Accordingly, IGF-I knockout mice show reduced density
of glutamatergic synapses (Trejo et al., 2007). Importantly,
IR expression and insulin activity in the brain are not
restricted to neurons. Insulin has been demonstrated to influence
proliferation and metabolism in insulin sensitive glial cells (Heni
et al., 2011). Collectively, all the above mentioned evidence
supports the positive effects of insulin on hippocampal synaptic
and structural plasticity.
Insulin and Hippocampal Adult
Neurogenesis
Hippocampus is one of the brain areas where newborn neurons
are generated throughout adulthood (Braun and Jessberger,
2014). Specifically, adult neurogenesis occurs in the subgranular
zone of the hippocampus of all mammals including humans
(Eriksson et al., 1998). NSCs populating this neurogenic
niche proliferate and differentiate to generate new neurons
(Kempermann et al., 2003). A proper balance between NSC
proliferation and their differentiation/maturation underlies the
maintenance of both the hippocampal stem cell niche and
the supply of newborn neurons that integrate into existing
circuits thus supporting cognitive functions under physiological
conditions and brain repair after injury (Castilla-Ortega et al.,
2011). Indeed, a growing number of studies indicates that
hippocampal neurogenesis plays a critical role in learning,
memory, and its impairment has been associated with cognitive
dysfunction in neurodegenerative disorders including AD (van
Praag et al., 2002; Taylor et al., 2013).
Insulin is a key trophic factor for brain development
and control of neurogenic niches. Indeed, neuroblast exit
from quiescence is regulated by insulin/IGF-I pathway
activation (Chell and Brand, 2010; Sousa-Nunes et al.,
2011). Evidence from in vitro and in vivo experiments
indicate that insulin and IGF-I promote neurogenesis by
modulating NSC proliferation, differentiation, and survival
(Brooker et al., 2000; Åberg et al., 2003). However, a chronic
hyper-activation of insulin/IGF-I signaling cascades can
cause premature depletion of the NSC reservoir (Sun, 2006).
Thus, insulin may produce either trophic or detrimental
effects on neural stem niche based on the timing and the
duration of stimulation.
Furthermore, calorie restriction has been clearly demonstrated
to reduce plasma levels of both glucose and insulin, in parallel
with increasing neurogenesis in the dentate gyrus (Lee et al.,
2002) and counteracting the age-related decline of stem cell
niche (Park et al., 2013). Nutrient deprivation may impact on
NSC compartment by inducing the expression of the brain-
derived neurotrophic factor (Bdnf) gene (Maswood et al.,
2004). In addition, calorie restriction may preserve the NSC
capacity to self-renew and differentiate by cell-autonomous
mechanisms involving metabolic sensors such as CREB and
the NAD-dependent histone deacetylase Sirtuin 1 (SIRT1).
In this regard, CREB is a nutrient-dependent transcription
factor regulating genes promoting neuronal differentiation and
survival (Lonze et al., 2002; Fusco et al., 2012b). Moreover,
SIRT1 is as an epigenetic repressor that modulates adult
neurogenesis in the subventricular zone and hippocampus
(Saharan et al., 2013). Calorie restriction also induces the
expression of SIRT1, which has been shown to functionally
impinge on CREB-dependent gene expression, thus highlighting
a novel molecular link between nutrient-dependent signaling
and brain health (Fusco et al., 2012a). Under metabolic and
oxidative stress, SIRT1 inhibits NSC self-renewal and induces
their differentiation (Prozorovski et al., 2008; Ma et al., 2014).
In summary, SIRT1 and CREB work as metabolic sensors
regulating proliferation and self-renewal of NSCs and controlling
their reservoir in the hippocampus (Fusco et al., 2016).
Conversely, abolishing the expression of genes encoding the
insulin-regulated FOXO transcription factors induces hyper-
proliferation of neural progenitors and rapid exhaustion of
stem cell niche (Renault et al., 2009). Similarly, aberrant
stimulation of the nutrient-dependent mTOR pathway causes
reduced self-renewal and accelerates NSC differentiation (Magri
et al., 2011). Together, this evidence confirms that nutrient
related signals control NSC fate under both physiological and
pathological conditions.
In addition, it is worth mentioning the close similarity
between the intracellular signaling pathways activated by insulin
and neurotrophins (Reichardt, 2006). In particular, CREB has
been shown to play a critical role in the neurotrophin-
triggered effects on neuronal differentiation, survival, and
plasticity, and it has been also characterized as metabolic
sensor modulated by fasting-related stimuli (Finkbeiner, 2000;
Altarejos and Montminy, 2011). Moreover, neurotrophic factors
as BDNF, ciliary neurotrophic factor (CNTF), and glial cell-
derived neurotrophic factor (GDNF) regulate adult neurogenesis
in multiple stages of NSC maturation and their expression is
affected by overnutrition and metabolic stress (Lindsay et al.,
1994). These evidence emphasizes the role of insulin as growth
factor for neural niche especially during the early stages of life.
Insulin Signaling and
Hippocampus-Dependent Cognitive Task
The evidence summarized above suggest that all aspects of
hippocampal plasticity (i.e., functional and structural synaptic
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plasticity, and adult neurogenesis) are strongly sensitive to the
modulation of insulin signaling into the brain. According to
the key role of hippocampal plasticity in learning and memory,
changes of insulin cascade in the hippocampus markedly affects
cognitive functions.
Heterozygous knockout mice for IR display lower preference
index in the novel object recognition (NOR) test (Nisticò et al.,
2012). Accordingly, Zucker rats show lower performance in
the Morris Water Maze (MWM) in parallel with impaired
insulin sensitivity (Kamal et al., 2013). Moreover, a recent study
performed on Goto-Kakizaki (GK) rats, a model of non-obese
type 2 diabetes (T2D), display spatial memory impairment in
Y-maze task and hippocampal synaptic dysfunction evaluated
by LTP (Duarte et al., 2019). Further, GK rats show a
reduction of SNAP25 and synaptophysin levels suggesting
synapse degeneration (Duarte et al., 2019). In addition, IRSp53
knockout mice show impaired learning and memory when
evaluated in both MWM and NOR tests (Kim et al., 2009).
However, forebrain-specific IRS2 deficiency improved memory
retention in the MWM task (Irvine et al., 2011), suggesting that
molecular hubs of insulin signaling may differentially interfere on
cognitive behavior.
In agreement with this finding, chronic brain stimulation by
8-week intranasal insulin administration improved memory in
humans (Benedict et al., 2004). Moreover, lower values of both
glycaemia and glycosylated hemoglobin (HbA1c) are associated
with better performance in memory tasks in humans (Kerti
et al., 2013). It has been shown that peripheral changes of
insulin signaling and sensitivity may affect brain health and
function although the results of these studies are controversial.
Learning and memory deficits in MWM have been demonstrated
in liver-specific IGF1 knockout mice (Trejo et al., 2007).
In addition, IGF-I antiserum administration to young rats
impairs learning in passive avoidance task (Lupien et al., 2003).
Conversely, intraperitoneal injection of insulin impairs retention
and spatial working memory in a dose-dependent manner
(Kopf and Baratti, 1999; Akanmu et al., 2009). It seems that
the negative impact of peripheral insulin administration on
cognitive functions may be due to the lowering of blood glucose
levels, as indicated by the positive effect of the simultaneous
glucose infusion (Kopf et al., 1998). In line with this hypothesis,
peripheral administration of insulin increases verbal memory
and attention in healthy subjects under euglycemic conditions
(Kern et al., 2001).
To avoid the side effects of systemic insulin administration,
Park et al. (2000) studied the impact of intracerebroventricular
injection of insulin in rats and found that insulin improved
cognitive performance in passive avoidance test. Accordingly,
intrahippocampal injection of insulin into the CA1 region
has been reported to enhance memory of rats in passive
avoidance test (Babri et al., 2007). More importantly, the
effects of intrahippocampal injection of insulin on cognitive
functions seem to be related to its dose. High doses of insulin
significantly ameliorate spatial learning and memory in the
MWM test, whereas low doses reduce cognitive performance
(Moosavi et al., 2006). It has been hypothesized that the negative
effects of insulin on spatial memory may be dependent on
either upregulation of GABAA receptors or downregulation of
AMPA receptors upon insulin treatment (Moosavi et al., 2006).
Finally, McNay et al. (2010) demonstrated that endogenous
intrahippocampal insulin signaling was required for memory
processing. These authors showed that acute injection of
insulin into the hippocampus at physiological doses enhanced
spatial memory via a PI3K-dependent mechanism (McNay
et al., 2010). Collectively, the results obtained in humans and
rodents suggest that insulin is fundamental for both memory
formation and retention.
EFFECTS OF BRAIN INSULIN
RESISTANCE ON HIPPOCAMPUS-
DEPENDENT FUNCTIONS
Data reviewed in the previous paragraphs support the view
that changes of either insulin signaling or insulin sensitivity
in the hippocampus may alter molecular pathways involved
in synaptic plasticity and adult neurogenesis, thereby leading
to reduced “mindspan” (the maintenance of mental abilities
throughout life) and increased risk of neurodegeneration (Kodl
and Seaquist, 2008). Accordingly, while calorie restriction
furthers neuronal survival and improves cognitive function
(Fusco and Pani, 2013), the excess of nutrients harms the
brain health and accelerates cognitive decline (Elias et al., 2012;
Sellbom and Gunstad, 2012). Nutrient excess causes hyper-
activation of insulin signaling in all tissues expressing IR, leading
to the desensitization of IR-dependent molecular cascades. BIR
decreases the ability of brain cells to respond to insulin and
abolishes both metabolic and cognitive effects of this hormone
(Kullmann et al., 2016). Specifically, this deficiency could be
caused by lower expression of IR or poor activation of insulin
signaling. IR downstream effectors may become insensitive to
the insulin stimulation, resulting in inability of brain cells to
respond to the hormone and leading to impairment of brain
plasticity. In the Western world, the incidence of metabolic
disorders, including insulin resistance, obesity and T2D, is
increasing at alarming rates in parallel with the prevalence
of cognitive decline (Cukierman-Yaffee, 2009). Obesity and
inflammation affect the insulin transport to the brain (Ketterer
et al., 2011) and low expression of IR has been reported in
patients with T2D (Kullmann et al., 2016). However, patients
with T2DM and/or obesity showed decreased insulin levels in
the cerebrospinal fluid despite higher levels of this hormone in
their plasma (Heni et al., 2014). In the following paragraphs,
we will summarize the mechanisms underlying the detrimental
effects of BIR on hippocampal plasticity and cognition, and the
epidemiological and experimental evidence supporting a link
between BIR and AD.
Alterations of Hippocampal Plasticity in
BIR Models
High-fat diet (HFD) is a well-established animal model of
metabolic disorders (Wong et al., 2016). HFD induces obesity
by compromising β-cell functions, promoting hyper-glycaemia,
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whole-body insulin resistance, and dyslipidemia, and
increasing free fatty acids in the blood. Many studies
have investigated the structural and functional changes of
neuroplasticity in experimental models of insulin resistance
(Fadel and Reagan, 2016).
More specifically, HFD produces detrimental effects on brain
functions including decreased neurogenesis in the dentate gyrus
(Lindqvist et al., 2006), alteration of BBB integrity (Freeman and
Granholm, 2012) and changes in both spine density and synapse
formation (Stranahan et al., 2008a). HFD also impairs insulin
signaling in the hippocampus and reduces the expression of
synaptic proteins PSD-95 and synaptopodin (Arnold et al., 2014).
However, the most significant effects occur on activity-dependent
synaptic plasticity. Indeed, Zucker rats show impairment in LTP
at CA3–CA1 synapses in parallel with loss of insulin sensitivity
(Kamal et al., 2013). Moreover, IR heterozygous knockout mice
display normal levels of both basal synaptic transmission and
LTP that, however, fails to be consolidated due to reduced Akt
activation (Nisticò et al., 2012).
Obesity and T2D have been demonstrated to induce
hippocampal insulin resistance through different metabolic
changes including alteration of hypothalamic-pituitary-adrenal
(HPA) axis leading to elevated levels of glucocorticoids (Plotsky
et al., 1992). Accordingly, glucocorticoids stimulation inhibits
translocation of GLUT4 to the plasma membrane in the rat
hippocampus (Piroli et al., 2007). Moreover, Stranahan et al.
showed that restoring physiological levels of glucocorticoids
in insulin resistant db/db mice rescued the impairment of
hippocampal synaptic plasticity (Stranahan et al., 2008b).
A different model of BIR is obtained by intracerebral injection of
streptozotocin, which impairs cognitive function by reducing the
activity of the neuroprotective protein SIRT1 (Du et al., 2014).
As mentioned before, SIRT1 cooperates with the transcription
factor CREB promoting the CREB-dependent expression of
the neuroplasticity-related gene Bdnf (Jeong et al., 2012).
To better clarify the functional role of hippocampal insulin
resistance, Grillo et al. (2015) silenced the expression of IR in
the hippocampus by injecting lentiviral particles harboring IR
antisense sequence. This experimental model showed deficits
in hippocampal synaptic transmission and spatial learning,
in parallel with downregulation of NMDA subunit GluN2B
expression and lower phosphorylation of AMPA subunit GluA1,
without altering peripheral metabolic parameters (i.e., body
weight, adiposity, and glucose homeostasis) (Grillo et al., 2015).
Recently, we described a novel link between BIR and
altered glutamate receptor function underlying the HFD-
dependent impairment of hippocampal synaptic plasticity
(Spinelli et al., 2017). In particular, we found that HFD induced
accumulation of palmitic acid and increased FOXO3a-dependent
expression of palmitoyl-transferase zDHHC3 leading to
GluA1 hyper-palmitoylation in the hippocampus. Accordingly,
in vitro stimulation of hippocampal neurons with a cocktail
of insulin and palmitic acid replicated the in vivo molecular
changes, inhibiting the GluA1 localization at the synaptic
membrane and AMPA currents at glutamatergic synapses.
Finally, either silencing of zDHHC3 or overexpression of the
palmitoylation-deficient GluA1 mutant in the hippocampus
abolished the insulin resistance-dependent impairment of
synaptic plasticity (Spinelli et al., 2017). Of course, aberrant
palmitoylation of other zDHHC3 targets (e.g., GABAA RG2) may
contribute to the detrimental effects of HFD on hippocampus-
dependent learning and memory. However, our study adds a
new layer to the hippocampal synaptic plasticity regulation by
insulin signaling deterioration and proposes a novel molecular
mechanism potentially linking BIR and cognitive decline.
Other mechanisms underlying fatty acid-driven learning
deficits involve cholesterol dysmetabolism, oxidative stress,
endothelial dysfunctions, and neurotrophin depletion. Mice
fed with HFD show higher levels of reactive oxygen species
(ROS), superoxide, and peroxynitrite into the brain, leading
to lower level of brain-derived neurotrophic factor (BDNF)
and impaired cognition performance evaluated by spatial task
(Wu et al., 2004). Moreover, epidemiological studies showed
that diets enriched in cholesterol (HCD) were associated with
poor cognitive performance in humans (Requejo et al., 2003).
HCD diet also induced impairment of spatial and working
memory due to microglial activation and alteration of the BBB
integrity in rats (Chen et al., 2018). Interestingly, feeding obese
rodents with HFD inhibited the transport through the BBB of
neuroendocrine molecules, such as ghrelin and leptin, which
promote synaptic plasticity and cognitive functions (Banks et al.,
2008; Kanoski et al., 2013; Mainardi et al., 2017). Finally, HFD
has been shown to induce activation of microglia and astrocytes,
and increase of pro-inflammatory cytokines/mediators such as
cyclooxygenase 2, TNF-α, IL-1-β, and IL-6 in the hippocampus
of mice (Thirumangalakudi et al., 2008; Duffy et al., 2019).
In summary, metabolic diseases affecting insulin signaling
may impair the synaptic function through a plethora of
molecular mechanisms targeting neurons, astrocytes, endothelial
or inflammatory cells.
Cognitive Impairment in BIR Models
Epidemiological evidence indicate that metabolic alterations
occurring in T2D, such as hyper-glycaemia and hyper-
insulinaemia, positively correlate with cognitive impairment
and diabetic patients exhibit higher susceptibility to develop
dementia (Cukierman-Yaffee, 2009). Dysregulation of glucose
homeostasis increases the risk of dementia in both diabetic and
non-diabetic patients (Crane et al., 2013) and is associated with
reduced hippocampal volume and cognitive decline (Kerti et al.,
2013). Furthermore, longitudinal studies demonstrated that also
Type 1 diabetes (T1D) patients were affected by mild-severe
cognitive impairment related to the age of onset of the disease
and the microvascular complications (Moheet et al., 2015;
Nunley et al., 2015). Insulin administration is crucial to promote
glucose homeostasis in these patients and to reduce the vascular
complications but it increases the risk for hypoglycemic episodes,
which negatively impact on cognitive functions (Desrocher and
Rovet, 2004). However, the role of hypo- or hyper-insulinemia in
T1D-related cognitive alterations has still to be clarified.
Numerous clinical studies revealed worse cognitive
performance and earlier age incidence of all-cause dementia
in subjects with T2D (Davis et al., 2017; Callisaya et al., 2019).
Accordingly, meta-analysis studies showed that in diabetic
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patients the risk for all types of dementia is increased by 60–73%
(Gudala et al., 2013; Chatterjee et al., 2016).
However, alteration of brain insulin signaling may negatively
impact on brain function also in the absence of T2D and
before the onset of obesity. Several studies have demonstrated
deficits in hippocampal-dependent learning and spatial memory
associated with Western diet intake (Molteni et al., 2002;
Kanoski and Davidson, 2010). Interestingly, when Kanoski
and Davidson (2010) investigated both hippocampus-dependent
and hippocampus-independent memory retention ability after
different Western diet treatments, they found that only spatial
memory impairments occurred after short-term consumption.
This suggests that hippocampus is a brain area very sensitive
to metabolic stress, and memory impairment may arise before
the development of diet-induced metabolic alterations in
peripheral tissues. Accordingly, few days of HFD regimen
were sufficient to cause cognitive impairment in rats evaluated
with MWM test (Murray et al., 2009). High caloric intake
also affected hippocampus-dependent non-spatial learning and
memory tasks and these results were related to changes of the BBB
integrity. Specifically, high energy diet consumption reduced the
expression of tight junction proteins selectively causing increased
blood-to-brain permeability in the hippocampus (Kanoski and
Davidson, 2010). The observed learning and memory deficits
are strikingly similar to the poor task performance and
cognitive impairment observed in patients with mild or severe
metabolic derangements, which strengthens the hypothesis that
hippocampal insulin resistance is a key mediator of diet-
dependent cognitive alterations. Therefore, cognitive dysfunction
related to HFD or obesity in otherwise healthy individuals may be
due to decreased insulin signaling and development of BIR in the
hippocampus (McNay et al., 2010).
Nevertheless, peripheral insulin resistance and diet-induced
obesity are correlated with some other changes that may
cause neurocognitive dysfunction. Indeed, they induce systemic
and central inflammation with high levels of circulating pro-
inflammatory interleukins that have been linked to impaired
executive function (Trollor et al., 2012). Obesity also alters HPA
axis causing enhanced secretion of glucocorticoids, which have
been associated with reduced hippocampal volume, memory
impairment and mood alterations (MacQueen and Frodl, 2011).
Moreover, mice specifically lacking the IR into the brain (NIRKO
mice) display changes in dopamine turnover associated with
anxiety and depressive-like behaviors (Kleinridders et al., 2015).
In addition, diet-induced microbiota dysbiosis can impact on the
gut-brain axis, thus promoting insulin resistance and cognitive
impairment (Daulatzai, 2014). Finally, HFD exposure during
early stages of life is associated with impaired learning and
spatial memory (Boitard et al., 2012), suggesting that alteration
of insulin signaling may negatively influence cognitive function
at each stage of life.
Brain Insulin Resistance, Brain Aging
and Neurodegenerative Diseases
While diabetes is known to increase the risk for dementia, the
underlying mechanisms linking insulin resistance, T2D and AD
are poorly understood. Undoubtedly, micro- and macro-vascular
complications of T2D may increase the risk of cerebrovascular
disease, cognitive impairment and vascular dementia (Gorelick
et al., 2011). Moreover, white matter disease, alteration of
the BBB and neuro-inflammation may play a pathophysiologic
role (Hsu and Kanoski, 2014). However, hyper-insulinaemia
promotes the formation of advanced glucose end products
and ROS causing neurotoxicity and brain damage (Brownlee,
2001). Despite insulin exerts a neurotrophic role at moderate
concentrations, higher levels of the hormone may be associated
with increased deposition of amyloid-β (Aβ) in the brain due to
competition for their common and main clearance mechanism,
the insulin-degrading enzyme (Farris et al., 2003). In this regard,
AD has been defined a form of type 3 diabetes, based on the
evidence of BIR development in the AD brain (Steen et al.,
2005; Bedse et al., 2015; Sposato et al., 2019). The insulin
synthesis decreases during aging and AD progression in brain
areas such as frontal cortex, hippocampus, and hypothalamus
(Frolich et al., 1998). In addition, Aβ inhibits insulin expression
in astrocytes (Pitt et al., 2017). Together, these studies indicate
a crosstalk between brain insulin signaling alteration and
Aβ accumulation in neurodegenerative diseases. Accordingly,
experimental data obtained from neuroimaging and biomarker
studies revealed that T2D patients showed alterations of both
brain glucose metabolism and cerebrospinal fluid including
phosphorylated tau, which are reminiscent of changes observed
in AD (Baker et al., 2011; Moran et al., 2015). In addition,
analysis of AD postmortem brains revealed insulin signaling
alterations in hippocampal tissues resembling the biochemical
features of insulin resistance in parallel with histopathological
hallmarks of neurodegeneration (Talbot et al., 2012; Tramutola
et al., 2015). Moreover, tau is hyper-phosphorylated in the
brain of NIRKO mice (Schubert et al., 2004) and BIR has
been associated with tau pathology in AD human brains
(Yarchoan and Arnold, 2014).
Interestingly, T2D and AD also share several metabolic
derangements promoting brain aging. AD patients show hyper-
insulinaemia and decreased peripheral insulin sensitivity (Craft
et al., 1996), whereas insulin levels in cerebrospinal fluid are
reduced (Craft et al., 1998). Accordingly, sustained peripheral
hyper-insulinaemia can reduce the transport of insulin into the
brain due to the lower expression of IR at the BBB (Schwartz
et al., 1990). Brain insulin uptake is also impaired in both aging
and AD independently by T2D (Frolich et al., 1998). Recent
evidence suggests that insulin may influence Aβ deposition
and AD-dependent impairment of both synaptic plasticity and
memory formation (Cholerton et al., 2013). Intranasal insulin
administration has been demonstrated to improve cognitive
function in humans (Hallschmid et al., 2007; Reger et al.,
2008). However, recent data about a clinical trial with mild
cognitive impairment (MCI) or moderate AD patients revealed
no significant effects of long-term intranasal insulin delivery on
cognitive performance in memory task (Craft et al., 2017).
Finally, genetic and experimental data about insulin degrading
enzyme and, more recently, the Aβ metabolism regulation
by sortilin related VPS10 domain containing receptor 1
(SorCS1) gene suggest novel mechanistic links between BIR
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and AD (Lane et al., 2010; Wang et al., 2015). Thus, BIR
seems to play a pivotal role at the crossroad between
metabolic and neurodegenerative diseases, independently from
the cerebrovascular mechanisms.
BIOMARKERS OF BRAIN INSULIN
RESISTANCE
In view of the close relationship among metabolic diseases,
BIR and cognitive decline, it is emerging the need to identify
biomarkers able to detect BIR before, or possibly even in
the absence of, peripheral insulin resistance, that may be
predictive of age- and dementia-related cognitive impairment.
Ideal biomarkers should be reliable, simple to measure, non-
invasive and inexpensive (Noel-Storr et al., 2013). In this regard,
the dosage of both Aβ and tau proteins in the cerebrospinal
fluid is invasive and most likely indicative of a pathology
already under development. For these reasons, in the last
years several studies focused on evaluation of brain glucose
metabolism and analysis of brain-derived extracellular vesicles
extracted from the blood as biomarkers of BIR and early-phase
cognitive decline.
Cerebral glucose metabolism is tightly correlated with
neuronal activity (Simpson et al., 2007). Therefore, imaging of
local brain hypo-metabolism can be used to visualize areas of
reduced synaptic activity. The most frequently used method
of brain metabolic imaging is positron emission tomography
(PET) with (18F)fluorodeoxyglucose (FDG) (Cohen and Klunk,
2014). Reduced cerebral glucose metabolism represents one
of the earliest signs of AD, and studies in both humans
and experimental models suggest that altered brain glucose
metabolism is associated with AD progression (Kapogiannis and
Mattson, 2011; Ishibashi et al., 2015).
Recent work have identified in GK rats reduced glutamine
synthesis and impairment of the glutamate-glutamine cycle
between astrocytes and neurons, driving to diabetes-induced
neurodegeneration and cognitive dysfunction (Girault et al.,
2017). In a mouse model of AD, impaired glucose transport
through the BBB and decreased cerebral lactate release during
neuronal activity occur at early stages of the phenotype (Merlini
et al., 2011). Dysregulated brain glucose metabolism resembling
changes observed in AD patients has been observed in metabolic
disorders such as obesity or T2D (Tschritter et al., 2006,
2007). However, whether neuroimaging changes of brain glucose
metabolism anticipate the onset of neurodegeneration or are
related to the development of BIR in the same brain areas remain
still poorly understood.
More recently, molecular strategies have been developed
to selectively isolate brain-derived exosomes (BDE) from
biological fluids (Tschritter et al., 2006, 2007; Fiandaca et al.,
2015; Goetzl et al., 2016). Exosomes are extracellular vesicles
carrying information (e.g., proteins, lipids, and nucleic acids)
to distant cells, which are emerging as novel potential
biomarkers for human diseases (Tkach and Thery, 2016). Several
pathogenic proteins that are involved in neurodegenerative
diseases, including AD, are loaded into vesicles and then
extracellularly secreted via exosomes (Rajendran et al., 2006;
Sharples et al., 2008). More importantly, changes of insulin
resistance molecular markers (i.e., higher serine phosphorylation
and lower tyrosine phosphorylation of IRS-1) have been
found in neural-derived exosomes extracted from blood of
AD patients compared to age- and gender-matched patients
with frontotemporal dementia or T2D (Kapogiannis et al.,
2015). These differences were detectable up to 10 years before
the onset of AD symptoms. Finally, exosomal biomarkers
of BIR were associated with higher brain atrophy in AD
patients (Mullins et al., 2017) emphasizing the potential role
of brain derived microvesicles as detectors of brain insulin
signaling and biomarkers of brain damage due to metabolic and
neurodegenerative disorders.
CONCLUSION
Molecules involved in metabolic homeostasis are now recognized
to exert a great influence on hippocampal plasticity, and
alteration of their equilibrium has a strong impact at the
functional and behavioral levels. Insulin exerts a trophic role
into the brain and it may also act as a signal of positive
metabolic homeostasis promoting neuroplasticity, which is
a high energy demanding process. Insulin plays a pivotal
role in the regulation of central nervous system homeostasis
and higher functions such as learning and memory, by
controlling both NSC fate and the activity of neuronal
network. In this regard, identifying the molecular targets
that underlie the effects of insulin on brain plasticity may
contribute to understand the mechanisms regulating neural
plasticity in health and metabolic diseases and reveal novel
targets in pathologies characterized by impaired neural
plasticity, especially AD.
Actually, we do not yet have an exhaustive understanding
of how systemic and brain insulin resistance are related to
brain aging and AD, but clinical and experimental evidence
indicates that insulin supplementation can be a therapeutic tool
for patients with cognitive impairment and an added value
in the treatment of dementia (Chapman et al., 2018; Santiago
and Hallschmid, 2019). The availability of BDE, such as other
biomarkers of brain metabolism detectable in the plasma, will
foster clinical studies to identify novel therapeutic approaches for
personalized medicine in neurodegenerative diseases.
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